Navidea Biopharmaceuticals Inc (NAVB)

[42Delta]

If, as was suggested on the OT board, that were true. One or both of the following would have been required upon execution of the transaction:
1. PM exceeding 10% common and reporting.
2. MG receiving one share from PM or more and reporting.
Both of the above deadlines have long past.
Navidea cannot and would not exercise the conversion request unless being assured that the 10% blocker was not at risk. PM's most common method of accomplishing this is via short selling ahead of the conversion, or in lesser amounts, a long sale from their core common. In cases where Navidea is aware of a potential or actual filing not self reported as required by the SEC, they have the obligation to report on PM's behalf.

AS for DDbuyer, IMO he represents the interests of PM exclusively. In some cases that can be good and in some cases he out-right stretches too far. I have nothing pro or con to say about any other individual or entity operating within the law. Each of us is responsible for our own decisions and capable of reaching their own conclusions. And each of us are entitled to state their opinion.